Questions: Evolution of Gene Regulation and Cis-Elements

Question 1

Two closely related insect species differ dramatically in the pigmentation of their abdomens but have nearly identical amino acid sequences for their main pigmentation enzyme. Researchers discover a single nucleotide change in an abdomen-specific enhancer of the pigmentation gene in one species. What does this finding best illustrate?

• A. Convergent evolution — both species independently arrived at the same protein function through different mutations
• B. That mutations in modular cis-regulatory elements can produce significant phenotypic change without any alteration to protein structure or coding sequence
• C. That transcription factors, not cis-elements, are the primary substrate for morphological evolution
• D. That coding sequence evolution is insufficient to explain any morphological difference between species

Answer: (B)

This is the central principle of regulatory evolution: phenotypic differences between species (or populations) often arise not from differences in what proteins exist, but from differences in when, where, and how much those proteins are produced. A single nucleotide change in an abdomen-specific enhancer alters gene expression in exactly one tissue context without affecting the protein's function or its expression anywhere else. Option C overstates the claim — coding mutations do drive some evolution; the point is that cis-regulatory mutations are a *primary* substrate, especially for morphological traits where coding changes would be too pleiotropically disruptive.

Question 2

Why are mutations in tissue-specific enhancers often more evolvable than mutations in the protein-coding sequence of the same gene?

• A. Enhancers mutate at higher rates than coding sequences, providing more raw material for selection
• B. Coding mutations that change protein function typically affect every tissue where that protein acts, creating fitness costs in other contexts; enhancer mutations alter expression in one tissue or developmental stage while leaving all other expression contexts intact
• C. Proteins are more structurally constrained than regulatory DNA, so proteins cannot evolve new functions at all
• D. Enhancers are shielded from purifying selection because they are non-coding, allowing mutations to accumulate and be sampled by positive selection

Answer: (B)

The key concept is pleiotropy. Most developmental genes are expressed in multiple tissues and participate in multiple processes. A coding mutation that makes the protein better in one context may impair it in others, because the same protein sequence must now serve all contexts simultaneously. Cis-regulatory elements are modular — a tissue-specific enhancer drives expression only in that tissue. A mutation in it affects only that context, leaving the gene's essential functions elsewhere completely undisturbed. This modularity dramatically reduces the pleiotropic costs of regulatory mutations, making them much more likely to be selectively fixed as adaptive changes.

Question 3

The same protein-coding sequence can produce different phenotypes in related species if the cis-regulatory elements controlling that gene's expression have diverged.

• T. True
• F. False

Answer: True

This is the core empirical claim of regulatory evolution, supported by many examples. The *yellow* gene in Drosophila and *Pitx1* in stickleback fish both show this pattern: the protein sequences are nearly identical across species, but evolutionary changes in specific enhancers have altered the spatial or temporal expression of these proteins in ways that produce dramatically different morphologies (pigmentation patterns, skeletal structures). Expression pattern differences — not protein differences — are the phenotypic driver. This also explains much of the human-chimpanzee morphological difference despite ~99% coding sequence similarity.

Question 4

The near-identical protein-coding sequences of humans and chimpanzees (~99% similar) indicate that phenotypic differences between the two species is expected to arise primarily from differences in gene copy number rather than from gene regulation.

• T. True
• F. False

Answer: False

Gene copy number variation is one factor, but a large proportion of human-chimpanzee phenotypic differences — brain size, limb proportions, facial structure, development timing — are attributable to cis-regulatory divergence: changes in enhancers, promoters, and silencers that alter the spatial, temporal, and quantitative expression of shared genes. The fact that proteins are nearly identical is precisely what makes this a compelling case for regulatory evolution: the phenotypes diverged substantially while the protein toolkit remained nearly constant, which means expression differences (regulated by cis-elements) must account for much of the divergence.

Question 5

Why does the pleiotropy of most developmental genes make regulatory evolution preferable to coding sequence evolution as a mechanism for morphological adaptation?

Model answer: Pleiotropy means a gene is expressed in multiple tissues and developmental contexts, often performing essential functions in each. A coding mutation that improves the protein's performance in one context — say, making an enzyme more active in a limb bud — alters the protein's properties everywhere it is expressed, potentially disrupting its function in the gut, the nervous system, or elsewhere. The fitness cost of disrupting these other contexts may outweigh the benefit in the target tissue. Cis-regulatory elements are modular: a tissue-specific enhancer drives expression only in that tissue. A mutation in that enhancer can alter expression in the target tissue while leaving every other expression context intact, because each context has its own regulatory elements. This independence of regulatory modules means selection can fine-tune gene expression in one context without paying the pleiotropic cost, making cis-regulatory mutations far more likely to be selectively advantageous when morphological change in a specific tissue is needed.

This reasoning explains a broad empirical pattern: genes that are highly pleiotropic (expressed in many tissues, essential in most) tend to evolve slowly at the coding sequence level but show extensive regulatory divergence. The regulatory evolution provides a 'safe' path to phenotypic change that avoids disrupting essential conserved functions.